Indication
Malignant paraganglioma
Malignant paraganglioma is a rare neuroendocrine neoplasm arising from extra-adrenal chromaffin or non-chromaffin neural crest tissue within the sympathetic or parasympathetic nervous systems. Read more about Malignant paraganglioma
1 drugs 1 manufacturers
Drugs that treat it
Common Malignant paraganglioma therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMalignant paraganglioma is a rare neuroendocrine neoplasm arising from extra-adrenal chromaffin or non-chromaffin neural crest tissue within the sympathetic or parasympathetic nervous systems.
Pathophysiologically, malignancy is defined by the presence of distant metastases in non-chromaffin tissues where paraganglionic cells are normally absent, most frequently affecting bones, regional lymph nodes, the liver, and lungs.
Clinically, these tumors can develop in adults or children and may be sporadic or linked to germline mutations, such as in the succinate dehydrogenase genes.
Sympathetic lesions typically produce excessive catecholamines leading to paroxysmal hypertension, headaches, diaphoresis, and tachycardia, whereas parasympathetic variants usually arise in the head and neck and predominantly present with painless local masses or cranial nerve deficits.
- nih.gov
Malignant paraganglioma is a rare neuroendocrine neoplasm arising from extra-adrenal chromaffin or non-chromaffin neural crest tissue within the sympathetic or parasympathetic nervous systems Sympathetic lesions typically produce excessive catecholamines leading to paroxysmal hypertension, headaches, diaphoresis, and tachycardia, whereas parasympathetic variants usually arise in the head and neck and predominantly present with painless local masses or cranial nerve deficits
- nih.gov
Malignant paraganglioma is a rare neuroendocrine neoplasm arising from extra-adrenal chromaffin or non-chromaffin neural crest tissue within the sympathetic or parasympathetic nervous systems Pathophysiologically, malignancy is defined by the presence of distant metastases in non-chromaffin tissues where paraganglionic cells are normally absent, most frequently affecting bones, regional lymph nodes, the liver, and lungs
- nih.gov
Malignant paraganglioma is a rare neuroendocrine neoplasm arising from extra-adrenal chromaffin or non-chromaffin neural crest tissue within the sympathetic or parasympathetic nervous systems
- mdpi.com
Malignant paraganglioma is a rare neuroendocrine neoplasm arising from extra-adrenal chromaffin or non-chromaffin neural crest tissue within the sympathetic or parasympathetic nervous systems Clinically, these tumors can develop in adults or children and may be sporadic or linked to germline mutations, such as in the succinate dehydrogenase genes
- nih.gov
Pathophysiologically, malignancy is defined by the presence of distant metastases in non-chromaffin tissues where paraganglionic cells are normally absent, most frequently affecting bones, regional lymph nodes, the liver, and lungs
- nih.gov
Pathophysiologically, malignancy is defined by the presence of distant metastases in non-chromaffin tissues where paraganglionic cells are normally absent, most frequently affecting bones, regional lymph nodes, the liver, and lungs Clinically, these tumors can develop in adults or children and may be sporadic or linked to germline mutations, such as in the succinate dehydrogenase genes
- columbiasurgery.org
Pathophysiologically, malignancy is defined by the presence of distant metastases in non-chromaffin tissues where paraganglionic cells are normally absent, most frequently affecting bones, regional lymph nodes, the liver, and lungs
- mayoclinic.org
Clinically, these tumors can develop in adults or children and may be sporadic or linked to germline mutations, such as in the succinate dehydrogenase genes Sympathetic lesions typically produce excessive catecholamines leading to paroxysmal hypertension, headaches, diaphoresis, and tachycardia, whereas parasympathetic variants usually arise in the head and neck and predominantly present with painless local masses or cranial nerve deficits
Personalize your experience
Follow Malignant paraganglioma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.